Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK4 | P11802 | 14/20 | 0.64 |
| ▸ | CDK1 | P06493 | 14/20 | 0.64 |
| ▸ | CCND1 | P24385 | 12/20 | 0.64 |
| ▸ | CCNB1 | P14635 | 11/20 | 0.64 |
| ▸ | CDK2 | P24941 | 10/20 | 0.64 |
| ▸ | CDK9 | P50750 | 8/20 | 0.64 |
| ▸ | CCNB2 | O95067 | 8/20 | 0.64 |
| ▸ | CCNB3 | Q8WWL7 | 8/20 | 0.64 |
| ▸ | CCNT1 | O60563 | 7/20 | 0.64 |
| ▸ | CCNA2 | P20248 | 5/20 | 0.64 |
| ▸ | CCNE1 | P24864 | 5/20 | 0.64 |
| ▸ | GSK3A | P49840 | 4/20 | 0.64 |
| ▸ | CDK6 | Q00534 | 4/20 | 0.64 |
| ▸ | CDK7 | P50613 | 3/20 | 0.64 |
| ▸ | CCND3 | P30281 | 3/20 | 0.64 |
| ▸ | CCNH | P51946 | 2/20 | 0.64 |
| ▸ | MNAT1 | P51948 | 2/20 | 0.64 |
| ▸ | MAPK15 | Q8TD08 | 2/20 | 0.64 |
| ▸ | CAMKK2 | Q96RR4 | 2/20 | 0.64 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7829623 | 1.00 | CDK4 (0.64) | CDK4CDK1CCND1CCNB1CDK2 | |
| Hydrochloric Acid SCHEMBL15636652 | 0.99 | CDK4 (0.65) | CDK4CDK1CCND1CCNB1CDK2 | |
| Hydrochloric Acid SCHEMBL4447778 | 0.99 | CDK4 (0.65) | CDK4CDK1CCND1CCNB1CDK2 | |
| SCHEMBL5735816 | 0.89 | CDK4 (0.53) | CDK4CDK1CCND1CCNB1CDK2 | |
| SCHEMBL23683032 | 0.88 | CDK4 (0.75) | CDK4CDK1CCND1CCNB1CDK2 | |
| SCHEMBL20181812 | 0.88 | CDK4 (0.75) | CDK4CDK1CCND1CCNB1CDK2 | |
| SCHEMBL24669074 | 0.87 | CDK4 (0.74) | CDK4CDK1CCND1CCNB1CDK2 | |
| SCHEMBL22580714 | 0.85 | CDK4 (0.67) | CDK4CDK1CCND1CCNB1CDK2 | |
| SCHEMBL8821026 | 0.83 | CDK4 (0.60) | CDK4CDK1CCND1CCNB1CDK2 | |
| SCHEMBL16722415 | 0.82 | CDK4 (0.64) | CDK4CDK1CCND1CCNB1CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018049233-A9 | INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 4 IN COMBINATION WITH CYCLIN-DEPENDENT KINASE INHIBITORS | STRANSKY NICOLAS (US) | 2018-07-12 | — | — | WO | claimed |
| WO-2018049233-A1 | INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR IN COMBINATION WITH CYCLIN-DEPENDENT KINASE INHIBITORS | STRANSKY NICOLAS (US) | 2018-03-15 | — | — | WO | claimed |
| EP-3129470-A1 | TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR | NOVARTIS AG (CH) | 2017-02-15 | — | — | EP | claimed |
| WO-2015157252-A1 | TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR | BROGDON, Jennifer (US) | 2015-10-15 | — | — | WO | claimed |
| EP-2866835-A1 | GPBP-1 INHIBITION AND ITS THERAPEUTIC USE | Fibrostatin, S.L. (ES) | 2015-05-06 | — | — | EP | claimed |
| WO-2014006020-A1 | GPBP-1 INHIBITION AND ITS THERAPEUTIC USE | FIBROSTATIN, S.L. (ES) | 2014-01-09 | — | — | WO | claimed |
| EP-1841401-A1 | REDUCTION OF HAIR GROWTH WITH SURVIVIN INHIBITORS | The Gillette Company (US) | 2007-10-10 | — | — | EP | claimed |
| WO-2006069192-A1 | REDUCTION OF HAIR GROWTH WITH SURVIVIN INHIBITORS | THE GILLETTE COMPANY (US) | 2006-06-29 | — | — | WO | claimed |
| EP-1420747-A2 | BENZOQUINONE ANSAMYCINS | Kosan Biosciences, Inc. (US) | 2004-05-26 | — | — | EP | claimed |
| WO-2003013430-A2 | BENZOQUINONE ANSAMYCINS | KOSAN BIOSCIENCES, INC. (US) | 2003-02-20 | — | — | WO | claimed |
| EP-4234685-A2 | METHODS FOR IMPROVING THE EFFICACY AND EXPANSION OF CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS | Novartis AG (CH) | 2023-08-30 | — | — | EP | disclosed |
| EP-3898626-A1 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS INHIBITORS OF FGFR TYROSINE KINASES | Array Biopharma, Inc. (US) | 2021-10-27 | — | — | EP | disclosed |
| EP-3898615-A1 | 7-((3,5-DIMETHOXYPHENYL)AMINO)QUINOXALINE DERIVATIVES AS FGFR INHIBITORS FOR TREATING CANCER | Array Biopharma, Inc. (US) | 2021-10-27 | — | — | EP | disclosed |
| EP-3891294-A1 | METHODS FOR TREATING CASTRATION-RESISTANT AND CASTRATION- SENSITIVE PROSTATE CANCER | Sumitomo Dainippon Pharma Oncology, Inc. (US) | 2021-10-13 | — | — | EP | disclosed |
| EP-3801769-A1 | COMBINATION THERAPY WITH CHIMERIC ANTIGEN RECEPTOR (CAR) THERAPIES | Novartis AG (CH) | 2021-04-14 | — | — | EP | disclosed |
| WO-2006094029-A2 | PHARMACEUTICAL FORMULATIONS CONTAINING 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN | KOSAN BIOSCIENCES INCOPORATED (US) | 2006-09-08 | — | — | WO | disclosed |
| WO-2006055472-A2 | SYNTHETIC DISCODERMOLIDE ANALOGS | KOSAN BIOSCIENCES INCORPORATED (US) | 2006-05-26 | — | — | WO | disclosed |
| WO-2005110398-A2 | PHARMACEUTICAL SOLUTION FORMULATIONS CONTAINING 17-AAG | KOSAN BIOSCIENCES, INC. (US) | 2005-11-24 | — | — | WO | disclosed |
| EP-1420747-A2 | BENZOQUINONE ANSAMYCINS | Kosan Biosciences, Inc. (US) | 2004-05-26 | — | — | EP | disclosed |
| WO-2003013430-A2 | BENZOQUINONE ANSAMYCINS | KOSAN BIOSCIENCES, INC. (US) | 2003-02-20 | — | — | WO | disclosed |